| Christopher Akinleye Alabi | |
| Workplaces: | Cornell University |
| Alma Mater: | New York University Stevens Institute of Technology California Institute of Technology |
| Thesis Title: | I. Synthesis and Proton Conductivity Studies of Mesostructured Organosilicates and Bitriazole-Polymer Composites. II. Targeted Nanoparticles for siRNA Delivery. |
| Thesis Url: | https://resolver.caltech.edu/CaltechETD:etd-05262009-145437 |
| Thesis Year: | 2009 |
| Doctoral Advisor: | Mark E. Davis |
| Academic Advisors: | Robert S. Langer David Israel Schuster |
| Website: | Alabi Lab |
Christopher A. Alabi is an American chemist and associate professor of chemistry at Cornell University. His research considers the design of sustainable materials and biomolecular therapeutics. He was elected to the American Institute for Medical and Biological Engineering in 2023.
Alabi studied chemistry at New York University, where he completed undergraduate research project with David Schuster.[1] He earned a joint bachelor's degree in chemistry and chemical engineering at NYU and the Stevens Institute of Technology. He later said that much of his success in academia came from his strong friendships and network at NYU.[2] He moved to the California Institute of Technology for his doctoral research, where he worked alongside Mark E. Davis. He joined Massachusetts Institute of Technology as an NIH Postdoctoral Fellow with Robert S. Langer.
In 2013 Alabi joined the faculty at Cornell University. His group make use of synthetic and analytical probes to understand and engineer macromolecular therapeutics. He creates sequence-defined macromolecules for stimuli-response and identifies optimised drug delivery bioconjugates.[3]